scorecardresearch
Add as a preferred source on Google
Wednesday, January 14, 2026
TopicPharmaceutical companies

Topic: Pharmaceutical companies

Indore firm linked to cough syrup deaths in Cameroon told to halt manufacture, govt tells Parliament

Naturcold, cough syrup supplied by Riemann Labs, was linked to deaths of 12 kids in Cameroon in March. This is 1st admission by govt of action taken in matter which was flagged by WHO.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

On Camera

The killing of a Minnesota woman by ICE agent has awoken the ‘tech Left’

‘We all bear a collective responsibility to speak up and not be silent when we see things like the events of the last week,’ Jeff Dean, chief scientist at Google, wrote on X.

Coastal states Maharashtra, TN, Gujarat top India’s exports index, landlocked UP a surprise performer

Releasing Export Preparedness Index report, NITI Aayog CEO says Centre has ‘ticked a lot of boxes’, & responsibility of driving the next phase of export growth now rests with states.

Rafale deal to be inked in 2026, final assembly line in Nagpur, Indian firms to be roped in

The proposed project costing about Rs 3.25 lakh crore will entail procurement of 18 aircraft in fly away condition & the rest made in India with up to 60% indigenous content.

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.